logo

Cti Biopharma Corp. (CTIC)



Trade CTIC now with
  Date
  Headline
5/3/2018 4:04:05 PM CTI BioPharma Q1 Loss Per Share $0.08 Vs Loss $0.71 Last Year
3/9/2018 7:01:38 AM CTI BioPharma Announces Publication Of Pacritinib Phase 3 PERSIST-2 Clinical Trial In JAMA Oncology
3/7/2018 4:02:53 PM CTI BioPharma Q4 Net Loss $14.3 Mln Or $0.33 Per Share Vs Net Loss $6.4 Mln Or $0.23 Per Share Last Year
2/13/2018 7:02:04 AM CTI BioPharma Says Closes Underwritten Public Offering Of 20 Mln Shares At $3.00/shr
2/9/2018 7:01:50 AM CTI BioPharma Prices Public Offering Of 20 Mln Shares Of Common Stock
2/5/2018 7:56:02 AM CTI BioPharma Launches Proposed Public Offering Of Shares
1/25/2018 4:41:42 PM CTI BioPharma Reincorporates In State Of Delaware, Delists From Borsa Italiana MTA Exchange
1/18/2018 1:32:10 AM CTI BioPharma Expects To Receive $10 Mln Milestone Payment From Teva For FDA Approval Of TRISENOX
9/26/2017 1:31:51 AM CTI BioPharma Appoints Laurent Fischer As New Chairman; Promotes David H. Kirske To CFO And Bruce Seeley To COO
8/3/2017 4:02:46 PM CTI BioPharma Q2 EPS $0.03 Vs Loss $0.71 Last Year